ArticleFrontiers in neurology2025
Comparative analysis of endoscopic-assisted burr hole craniostomy and two burr hole craniostomy in the treatment of septated chronic subdural hematoma.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Unexpected ocular morbidity after middle meningeal artery embolization: Lessons learned from a case of anastomotic-related diplopia.World journal of clinical cases · 2025Article
- Neuroendoscopic surgery for septated chronic subdural hematoma.Frontiers in surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To conduct a retrospective comparative analysis of endoscopic-assisted burr hole craniostomy (EBHC) vs. two burr hole craniostomy (TBHC) in the management of septated chronic subdural hematoma (sCSDH). Methods: This study employed a retrospective cohort design, encompassing 87 patients diagnosed with sCSDH who were admitted for EBHC or TBHC between January 2018 and December 2023. Among these patients, 48 underwent EBHC, while 39 received TBHC. The primary outcome measure was the recurrence rate within 6 months following surgery. Secondary outcomes included clinical outcomes at discharge and 6 months, duration of hospitalization, and duration of drainage tube placement. Results: The recurrence rates were comparable between EBHC and TBHC groups (12.5% vs. 10.3%, Conclusion: TBHC is an effective intervention for sCSDH, offering a less invasive alternative with shorter operative duration and comparable recurrence rates to EBHC. Nonetheless, the efficacy of this approach requires further validation through large, multicenter studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.